| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1187830-91-6 | 1,2,4,5,6,7-Hexahydro-3H-pyrazolo[3,4-c]pyridin-3-one hydrochloride | C6H9N3O.HCl |
| 1187926-84-6 | Lansoprazole N-Trifluoroethyl Impurity;2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1-(2,2,2-trifluoroethyl)benzimidazole | C18H15F6N3O2S |
| 1187926-85-7 | 2-[[(3-Methyl-4-nitro-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole | C14H12N4O4S |
| 1187926-96-0 | tert-Butyl (2-bromo-4,5-dimethylphenyl)carbamate | C13H18BrNO2 |
| 1187927-12-3 | (3R)-3-(Chloromethyl)-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester | C10H18ClNO2 |
| 1187927-21-4 | 3-[(1S)-1-Aminoethyl]benzoic acid methyl ester | C10H13NO2 |
| 1187928-88-6 | (3R)-3-Morpholinecarboxylic acid hydrochloride (1:1) | C5H9NO3.HCl |
| 1187929-04-9 | (3S)-3-Morpholinecarboxylic acid hydrochloride (1:1) | C5H9NO3.HCl |
| 1187929-25-4 | 2-(Morpholin-2-yl)acetic acid hydrochloride | C6H11NO3.HCl |
| 1187929-33-4 | (R)-3-(Aminomethyl)morpholine-4-carboxylic acid tert-butyl ester | C10H20N2O3 |
| 1187929-55-0 | (3R)-3-Morpholinecarboxylic acid methyl ester hydrochloride (1:1) | C6H11NO3.HCl |
| 1187929-79-8 | (S)-3-(Aminomethyl)morpholine-4-carboxylic acid tert-butyl ester | C10H20N2O3 |
| 1187929-80-1 | alpha,alpha-Dimethyl-3-pyridinemethanamine hydrochloride (1:2) | C8H12N2.2(HCl) |
| 1187929-81-2 | tert-Butyl (azetidin-3-ylmethyl)carbamate oxalate | C9H18N2O2.C2H2O4 |
| 1187929-84-5 | (3S)-3,4-Thiomorpholinedicarboxylic acid 4-(1,1-dimethylethyl) ester | C10H17NO4S |
| 1187929-87-8 | 5,6,7,8-Tetrahydro-8-quinolinamine hydrochloride (1:2) | C9H12N2.2(HCl) |
| 1187930-24-0 | 5-Fluoro-2-methylbenzenecarboximidamide hydrochloride | C8H9FN2.HCl |
| 1187930-49-9 | 1,3,8-Triazaspiro[4.5]decan-4-one hydrochloride (1:2) | C7H13N3O .2ClH |
| 1187930-63-7 | beta-Amino-2-pyridineethanol hydrochloride (1:2) | C7H10N2O.2(HCl) |
| 1187931-23-2 | (2R)-2-(Aminomethyl)-1-pyrrolidinecarboxylic acid phenylmethyl ester | C13H18N2O2 |
| 1187932-09-7 | 2-Aminopyridin-4-ol hydrochloride;2-Amino-4-hydroxypyridine hydrochloride | C5H6N2O.HCl |
| 1187932-11-1 | (S)-tert-Butyl (1-(2-bromophenyl)ethyl)carbamate | C13H18BrNO2 |
| 1187932-25-7 | N-[(1R)-1-(3-Bromophenyl)ethyl]carbamic acid 1,1-dimethylethyl ester | C13H18BrNO2 |
| 1187932-30-4 | 4-Bromopyridin-3-amine dihydrochloride | C5H7BrCl2N2 |
| 1187933-06-7 | Octahydro-5H-pyrrolo[3,4-c]pyridine-5-carboxylic acid 1,1-dimethylethyl ester hydrochloride (1:1) | C12H22N2O2.HCl |
| 1187933-13-6 | 2-[2-(Trifluoromethyl)phenyl]cyclopropanecarboxylic acid | C11H9F3O2 |
| 1187933-29-4 | 1-(4-Chlorophenyl)-3-azetidinecarboxylic acid;1-(4-Chlorophenyl)azetidine-3-carboxylic acid | C10H10ClNO2 |
| 1187945-05-6 | 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)picolinic acid | C20H12ClF4N3O4 |
| 1187954-57-9 | 2-(4-(4-(4-(Diphenylmethylene)piperidin-1-yl)-1-hydroxybutyl)phenyl)-2-methylpropanoic acid | C32H37NO3 |
| 1187966-91-1 | Pitavastatin Impurity 1;(3R,5S)-5-(6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic acid | C25H24FNO4 |
| 1187974-47-5 | (Tetrahydro-2H-pyran-4-yl)hydrazine hydrochloride (1:2) | C5H12N2O.2(HCl) |
| 1187983-97-6 | 4-Bromo-2-(trifluoromethoxy)benzonitrile | C8H3BrF3NO |
| 1188044-87-2 | 6-Fluoro-2,3-dihydro-1H-indene-1-acetic acid | C11H11FO2 |
| 1188083-45-5 | 2-((4-Bromophenyl)(methoxy)methylene)malononitrile | C11H7BrN2O |
| 1188094-10-1 | B-2-Phenanthrenyl-boronic acid | C14H11BO2 |
| 1188263-46-8 | 5,6,7,8-Tetrahydro-4-methyl-2-quinazolinemethanamine hydrochloride | C10H15N3.HCl |
| 1188263-51-5 | Tizanidine-d<sub>4</sub> Hydrochloride | C9H4ClD4N5S.HCl |
| 1188263-67-3 | N-(3-Aminopropyl)-N-methylcarbamic acid 1,1-dimethylethyl ester hydrochloride | C9H20N2O2.HCl |
| 1188263-71-9 | 2-tert-Butoxycarbonylaminomethylpyrrolidine hydrochloride | C10H20N2O2.HCl |
| 1188263-74-2 | 2-(Aminomethyl)-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester hydrochloride (1:1) | C10H20N2O2.HCl |
| 1188264-09-6 | 3-(Aminomethyl)-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester hydrochloride (1:1) | C10H20N2O2.HCl |
| 1188264-39-2 | 3-(Bromomethyl)-3-oxetanecarboxaldehyde | C5H7BrO2 |
| 1188264-82-5 | N,1,3,5-Tetramethyl-1H-pyrazole-4-methanamine hydrochloride | C8H15N3.HCl |
| 1188264-95-0 | 4-Methyl-N-[2-(1-pyrrolidinyl)ethyl]benzenesulfonamide | C13H20N2O2S |
| 1188264-99-4 | tert-Butyl 2-(1-methyl-1H-pyrazol-4-yl)ethylcarbamate | C11H19N3O2 |
| 1188265-06-6 | 4,7-Dioxo-7-(4-methoxyphenyl)heptanoic acid ethyl ester;4-Methoxy-gamma,zeta-dioxobenzeneheptanoic acid ethyl ester | C16H20O5 |
| 1188265-31-7 | 3-Methoxy-4-oxo-1-piperidinecarboxylic acid 1,1-dimethylethyl ester | C11H19NO4 |
| 1188265-39-5 | N-3-Piperidinyl-2-benzothiazolamine hydrochloride | C12H15N3S.HCl |
| 1188265-57-7 | 2-Bromo-3-pyridinol 1-oxide hydrobromide | C5H4BrNO2.HBr |
| 1188265-73-7 | tert-Butyl 3-(2-hydroxyethyl)piperazine-1-carboxylate | C11H22N2O3 |